Professor Dame Sally Davies (TBC)
Dame Sally was appointed Chief Medical Officer (CMO) for England and Chief Medical Advisor to the UK government in March 2011, having held the post on an interim basis since June 2010. She is an independent adviser to the government on medical matters, with particular responsibilities regarding public health.
Dame Sally advocates globally on AMR. She has spoken on AMR at numerous events including the World Health Assembly side events, the G8 science ministers’ meeting in 2015, the Global Health Security Initiative in 2015, and the UN General Assembly side event in 2016.
She was chair of the 2013 AMR forum at the World Innovation Summit for Health (WISH) and was for three years the chair of the WHO Strategic and Technical Advisory Group on AMR.
Most recently, Dame Sally has been appointed a co-convener of the UN Inter-Agency Co-ordination Group on AMR, set up in response to the AMR declaration made at UNGA 2016.
Dame Sally received her DBE in 2009. She was elected Fellow of the Royal Society in 2014 and a member of the National Academy of Medicine, USA in 2015.
Professor Janet Hemingway
Janet Hemingway is Professor of Vector Biology at the Liverpool School of Tropical Medicine. She is also a Senior Technical Advisor on Neglected Tropical Diseases for the Bill and Melinda Gates Foundation, and has 38 years’ experience working on the biochemistry and molecular biology of specific enzyme systems associated with xenobiotic resistance.
Professor Hemingway was appointed the Director of LSTM in 2001 and stepped down on 1st January 2019, having overseen a period of exceptional growth of the organisation. This included the awarding of Higher Educational Institution Status & Degree Awarding powers to LSTM. This new status will facilitate expansion of both the research and teaching activities going forward.
Professor Hemingway was awarded the Commander of the British Empire (CBE) for services to the Control of Tropical Disease Vectors 2012. We look forward to hosting Professor Hemingway at the Congress.
Professor Peter Hotez
Peter J. Hotez, MD, PhD is the founding dean of the National School of Tropical Medicine and a professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, where he is also the Texas Children’s Hospital Endowed Chair of Topical Pediatrics.
He also services as Director of Texas Children’s Hospital Center for Vaccine Development, and the Baker Institute Fellow in Disease and Poverty at Rice University.
Dr Hotez’s research focuses on developing vaccines for neglected tropical disease such as hookworm infection, schistosomiasis, and Chagas disease. These diseases affect hundreds of millions of children and adults worldwide.
A renowned global health advocate, Dr. Hotez co-founded the Global Network for Neglected Tropical Diseases in 2006 as part of the Clinton Global Initiative. The Global Network for Neglected Tropical Diseases provides access to essential medicines for more than 450 million people.
He has also written op-eds and editorials for The New York Times, Los Angeles Times, Washington Post, and the Huffington Post. In 2014 he was selected by the US State Department and White House and US Science Envoy, focusing on science and vaccine diplomacy for the Middle East and North Africa.
Professor David Lalloo
Professor David Lalloo is the Director of the Liverpool School of Tropical Medicine (LSTM).
After spending three years in Papua New Guinea, he undertook clinical and laboratory research in Oxford before joining LSTM in 1999.
He has focused on clinical trials in the tropics, particularly in HIV related infections, malaria and envenoming. He currently has collaborations and studies in a number of countries including Malawi, Uganda, Sri Lanka, Vietnam and South Africa.
He holds an appointment as Honorary Consultant at the Royal Liverpool University Hospital and is Clinical Director of the Tropical Medicine Directorate and Director of the Wellcome Trust Liverpool Glasgow Centre for Global Health Research and Wellcome Trust Clinical PhD programme.
Through the Centre and PhD programme, he is instrumental in identifying and supporting young UK clinicians interested in tropical research and building scientific capacity overseas, working closely with the Malawi Liverpool Wellcome Trust Clinical Research Programme.
Professor David Molyneux
Professor Molyneux is an Honorary Professor at the Liverpool School of Tropical Medicine and Emeritus Professor of the University of Liverpool. He was Director of the Liverpool School of Tropical Medicine between 1991 and 2000. His work has been recognised by the award of Medals from the Royal Society of Tropical Medicine and Hygiene and the British Society for Parasitology- societies for which he has served as President.
Professor Molyneux has extensive experience working in Africa and the Middle East. He was awarded a DSc from Salford University and is a Doctor of Science Honoris Causa of Georgetown University, Washington, DC and is an Honorary Fellow of Liverpool John Moores University, UK for his work on neglected tropical diseases. He has been one of the key advocates in raising the profile of NTDs. They are now one of the priorities of the World Health Organisation and a target within the UN Sustainable Development Goals.
Dr. Katey Owen
Dr. Katey Einterz Owen is the Director for Neglected Tropical Diseases at The Bill & Melinda Gates Foundation. In this capacity, Katey has end-to-end responsibility for the Gates Foundation’s investment portfolio in controlling, eliminating, and eradicating the diseases of the London Declaration that collectively put at risk approximately one billion people in the world. The portfolio funds projects with global private and public partners across the value chain, from research and innovation through on-the-ground delivery of interventions in Africa and Asia.
Disease targets included polio, rotavirus, pneumonia, HIV, malaria, TB, Ebola, HPV, typhoid, ETEC, and shigella. Katey joined BMGF in 2013 from the pharmaceutical industry, after demonstrating success in vaccine development, manufacturing, and commercialization across a portfolio of vaccines. Her perspectives have also been shaped by her oldest sister, who spent her career as a primary care physician and health-district chief in rural northern Cameroun. Prior to joining the pharmaceutical industry, Katey carried out academic research on influenza at the National Institute for Medical Research in Mill Hill (London). She earned her PhD in molecular virology from Purdue University.
Professor Baron Peter Piot
Professor is the Director of the London School of Hygiene & Tropical Medicine and a Handa Professor of Global Health.
He was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations between 1995 and 2008.
A clinician and microbiologist by training, he co-discovered the Ebola virus in what was then known as Zaire in 1976, and subsequently led pioneering research on HIV and AIDS, women’s health and infectious diseases in Africa.
He is past president of the International AIDS Society and of the King Baudouin Foundation. In 1995 he was made a baron by King Albert II of Belgium, and in 2016 was awarded a UK honorary knighthood KCMG.
Professor Piot has received numerous awards for his research and service, including the Sir Patrick Manson Medal from RSTMH (2016), Canada Gairdner Global Health Award (2015), the Robert Koch Gold Medal (2015), the Prince Mahidol Award for Public Health (2014), and the Hideyo Noguchi Africa Prize for Medical Research (2013), the F.Calderone Medal (2003), and was named a 2014 TIME Person of the Year (The Ebola Fighters).
He has published over 580 scientific articles and 16 books, including his memoir, No Time to Lose.
Professor Chris Whitty (TBC)
We are delighted to announce Chris Whitty as a keynote speaker. Professor Whitty is a physician and epidemiologist who works in public health, science policy and clinical medicine, is Professor of Public and International Health at Liverpool School of Tropical Medicine and is a member of the RSTMH education and training committee.
Currently seconded as Chief Scientific Adviser, Department of Health and Social Care (DHSC) alongside LSHTM and NHS roles; this includes leading the National Institute for Health Research (NIHR), being first deputy Chief Medical Officer, and is responsible for supporting evidence-based health policy for the UK life sciences industry.
It is with great pleasure that we welcome Professor Whitty to our panel of keynote speakers.